Inve US ▾
VCVCEL

Vericel (VCEL) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Jul 30, 2026

Source: earnings call transcript

Vericel delivered strong Q2 FY26 results, driven by robust growth in both MACI and Burn Care franchises, leading to record revenue, profitability, and cash flow. The company raised its full-year revenue guidance and announced a $200 million share repurchase program, reflecting confidence in sustained growth and capital allocation strategy. Management emphasized continued investment in growth initiatives and opportunistic capital return.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.